Burkitt cell leukemia following therapy for hodgkin disease
โ Scribed by Victor H. Nassar; Julian Jacobs; Suzanne S. Mirra; Kishan J. Pandya; Sheldon Schwartz; John M. Bennett
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 403 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A 52-year-old man developed synchronous squamous-cell carcinoma of the larynx and middle one-thud of the esophagus following treatment for Hodgkin disease. This patient fell into the subgroup of patients treated by intensive radiation therapy followed by intensive chemotherapy. The link between the
The development of Burkitt cell leukemia (FABL3) [l] in a patient 7 years after successful treatment of Hodgkin's disease (HD) by combined modality (chemotherapy and radiotherapy) therapy is described. The B-cell nature of the leukemic blasts is shown by immunologic surface marker studies. While L3
The chest radiograms (CXR) of 102 patients with Hodgkin's disease presenting with mediastinal involvement at diagnosis were reviewed to assess the incidence and relevance of residual mediastinal abnormalities after therapy. All patients had completed planned treatment and had no evidence of persisti